Human Immunodeficiency Virus-2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe.

Berzow, D; Descamps, D; Obermeier, M; Charpentier, C; Kaiser, R; Guertler, L; Eberle, J; Wensing, A; Sierra, S; Ruelle, J; Gomes, P; Mansinho, K; Taylor, N; Jensen, B; Döring, M; Stürmer, M; Rockstroh, J; Camacho, R; Clin Infect Dis. 2021; 72(3):503-509

Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases

Kwik, M; Hainzl, S; Oppelt, J; Tichy, B; Koller, U; Bernardinelli, E; Steiner, M; Zara, G; Nofziger, C; Weis, S; Paulmichl, M; Dossena, S; Patsch, W; Soyal, SM; Int J Mol Sci. 2021; 22(7):

Preparing for future waves and pandemics: a global hospital survey on infection control measures and infection rates in COVID-19.

Matoori, S; Kuritzkes, DR; Goh, Y; Quek, ST; Wang, L; Sun, Z; di Marco, F; Borleri, D; Buoro, S; Fagiuoli, S; Ferrari, T; Rizzi, M; Raimondi, F; Cesa, S; Koh, DM; Froehlich, JM; Janssen, S; Lange, B; Egle, A; Erb, S; Mossdorf, E; Gutzeit, A; Antimicrob Resist Infect Control. 2021; 10(1): 170

The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8

Filipits, M; Rudas, M; Kainz, V; Singer, CF; Fitzal, F; Bago-Horvath, Z; Greil, R; Balic, M; Regitnig, P; Halper, S; Hulla, W; Egle, D; Barron, S; Loughman, T; OxxxLeary, D; Gallagher, WM; Hlauschek, D; Gnant, M; Dubsky, P CLIN CANCER RES. 2021; 27(21): 5931-5938.

Safety and efficacy of durvalumab with R-CHOP or R-2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

Nowakowski, GS; Willenbacher, W; Greil, R; Larsen, TS; Patel, K; Jager, U; Manges, RF; Trumper, L; Everaus, H; Kalakonda, N; Brown, P; Jorgensen, JM; Cunningham, D; DellxxxAringa, J; Fox, B; Rubio, ND; Kilavuz, N; Casadebaig, ML; Manzke, O; Munoz, J INT J HEMATOL. 2021;

ASCO 2021-an update on metastastic colorectal cancer

Weiss, L MEMO-MAG EUR MED ONC. 2021;

Position Paper on the Value of Extended Adjuvant Therapy with Neratinib for Early HER2+/HR+ Breast Cancer

Balic, M; Rinnerthaler, G; Bartsch, R BREAST CARE. 2021;

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6).

Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Hubalek, M; Petru, E; Sandholzer, M; Andel, J; Balic, M; Melchardt, T; Hauser-Kronberger, C; Schmitt, CA; Ulmer, H; Greil, R; Ther Adv Med Oncol. 2021; 13: 17588359211042301

Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.

Müller, M; Posch, F; Kiem, D; Barth, D; Horvath, L; Stotz, M; Schaberl-Moser, R; Pichler, M; Greil, R; Jost, PJ; Seeber, A; Amann, A; Schlick, K; Gerger, A; Riedl, JM; THER ADV MED ONCOL. 2021; 13: 17588359211039930

Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog-GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO Inhibition

Peer, E; Aichberger, SK; Vilotic, F; Gruber, W; Parigger, T; Grund-Groschke, S; Elmer, DP; Rathje, F; Ramspacher, A; Zaja, M; Michel, S; Hamm, S; Aberger, F CANCERS. 2021; 13(16): 4227